【24h】

Spectrofluorimetric study of eflucimibe-gamma-cyclodextrin inclusion complex.

机译:荧光荧光光谱法研究头孢氨苄-γ-环糊精包合物。

获取原文
获取原文并翻译 | 示例
           

摘要

Eflucimibe, a novel and highly potent acyl-coenzyme A cholesterol O-acyl-transferase (ACAT) inhibitor, is sparingly soluble in aqueous media and exhibits a very weak natural fluorescence. However, when increasing concentrations of gamma-cyclodextrin (gamma-CD) are added, an increase in the fluorescence signal is observed, attesting the formation of a non-covalent inclusion complex between eflucimibe and the gamma-CD. In this work, the stoichiometry of the complex and the corresponding association constant have been determined from fluorescence data by Benesi-Hildebrand's method (double reciprocal plots). As a result, a 1:1 stoichiometric ratio and a 20M(-1) formation constant were obtained. This apparent formation constant was determined in water containing 10% methanol, which was needed to improve 'aqueous' solubility of the drug in a CD-free medium. Owing to the extreme hydrophobicity of eflucimibe, these results provide valuable information for pharmaceutical formulation studies.
机译:Eflucimibe是一种新型且高效的酰基辅酶A胆固醇O-酰基转移酶(ACAT)抑制剂,微溶于水介质,并且显示出非常弱的天然荧光。但是,当添加浓度增加的γ-环糊精(γ-CD)时,观察到荧光信号增加,证明在依夫西米贝和γ-CD之间形成了非共价包合物。在这项工作中,通过Benesi-Hildebrand方法(双倒数图)从荧光数据确定了配合物的化学计量和相应的缔合常数。结果,获得了1:1的化学计量比和20M(-1)的形成常数。在包含10%甲醇的水中测定该表观形成常数,这对于提高药物在无CD介质中的“水”溶解度是必需的。由于头孢氨苄具有极强的疏水性,这些结果为药物制剂研究提供了有价值的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号